-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Karuna Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
- Karuna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $38.3M, a 64.4% increase year-over-year.
- Karuna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $74.6M, a 57.2% increase year-over-year.
- Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $74.6M, a 57.2% increase from 2022.
- Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $47.5M, a 59.2% increase from 2021.
- Karuna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.8M, a 121% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)